Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density

J Bone Miner Res. 2002 Jan;17(1):11-4. doi: 10.1359/jbmr.2002.17.1.11.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aged
  • Bone Density / drug effects*
  • Bone Remodeling / drug effects*
  • Female
  • Humans
  • Middle Aged
  • Models, Biological
  • Osteoporosis, Postmenopausal / drug therapy
  • Raloxifene Hydrochloride / therapeutic use*
  • Risk Factors
  • Selective Estrogen Receptor Modulators / therapeutic use*
  • Spinal Fractures / prevention & control*

Substances

  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride